Osteosarcoma
📧 Sign up to get email alerts when something new happens for Osteosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Genetic Characterisation of High-grade Paediatric Osteosarcomas
This document summarizes a completed clinical trial update focusing on the genetic characterization of high-grade paediatric osteosarcomas.
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma [Phase 2, Phase 3]
Clinical trial update evaluating zoledronic acid as a single agent or added to chemotherapy for high-grade osteosarcoma in Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma [Phase 1, Phase 2]
This is a pilot Phase 1/2 clinical trial evaluating a curcumin formulation and an ashwagandha extract in advanced osteosarcoma.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma [Phase 2]
A Phase 2 trial evaluating intensive chemotherapy for osteosarcoma has completed at St. Jude Children's Research Hospital.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Phase II Study of Intravenous Rexin-G in Osteosarcoma [Phase 2]
Phase II study of intravenous Rexin-G in osteosarcoma has completed. The update provides no detailed results in the snippet.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma [NA]
A Mayo Clinic-sponsored clinical trial investigating combination chemotherapy for patients undergoing surgery for newly diagnosed high-grade…
-
FDA approval · 2011-04-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for METHOTREXATE from Hikma Pharmaceuticals USA Inc., granting a supplemental approval for the g…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Study of Pemetrexed in Children With Recurrent Cancer [Phase 2]
Pemetrexed was studied in a Phase 2 trial in children with recurrent cancer across several pediatric tumor types, including osteosarcoma and…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Chemotherapy for Patients With Osteosarcoma [Phase 2]
A Phase 2 chemotherapy trial for osteosarcoma completed with results posted by the sponsor.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Clinical Studies of Gemcitabine-Oxaliplatin [Phase 2]
Phase 2 clinical studies of a gemcitabine-oxaliplatin regimen for pediatric central nervous system tumors, including medulloblastoma, have b…
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy [Phase 1, Phase 2]
Phase 1/2 study evaluating recombinant human thrombopoietin as supportive care for children receiving ifosfamide, carboplatin, and etoposide…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study [Phase 3]
A Phase III randomized trial evaluating pre-surgical chemotherapy versus immediate surgery with adjuvant chemotherapy for non-metastatic Ost…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [Phase 1]
This is a completed Phase 1 pilot study evaluating treatment for patients with metastatic and high-risk sarcomas and primitive neuroectoderm…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [Phase 1]
This Phase I trial of OncoLAR, with or without Tamoxifen, in osteosarcoma patients has completed.
-
FDA approval · 2007-04-30FDA Approved: METHOTREXATE — Original Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare's original application for Methotrexate (generic).
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse [Phase 2]
A Phase 2 trial of vinorelbine and cyclophosphamide in patients with refractory or relapsed tumors, including rhabdomyosarcoma, Ewing sarcom…